跳至主要内容
临床试验/CTRI/2024/10/075336
CTRI/2024/10/075336尚未招募2 期

A Comparative Clinical Study Of Shirodhara And Abhyanga With Tila Taila In Nidranasha w.s.r To Insomnia.

vdrutuja rangrao darekar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年10月24日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To study Difference between efficacy of shirodhara and abhyanga to reduce symptoms of nidranasha .

研究概览

简要总结

Title A comparative clinical study of shirodhara and abhyanga with tila taila in nidranasha w.s.r to insomnia .

Primary research question Is there any difference between efficacy of shirodhara and abhyanga with tila taila in nidranasha ?

Primary Hypothesis There is significant difference between efficacy of shirodhara and abhyanga with tila taila in nidranasha .

Null Hypothesis There is no difference between efficacy of shirodhara and abhyanga with tila taila in nidranasha .

Primary objective To compare shirodhara and abhyanga with tila taila in nidranasha .

Secondary objective To study literature aspect of shirodhara ,abhyanga , nidranasha and insomnia .

To prepare methodology and sop for clinical trial .

To conduct clinical trial

To assess efficacy after result .

Methodology Study design - Open label randomized comparative clinical trial .

Study centre- Hospital of our institution .

study population - Patients having classical sign and symptoms of nidranasha w.s.r to insomnia .

Overall duration of study -18 months

Sample size - 30 in each group , group A and B  Total 60 .

Inclusion criteria - Patients fulfilling the diagnostic criteria of nidranasha and insomnia .

Age group -20 to 60 years

Gender - both male and female

Patients irrespective of religion , economical status , education and occupation etc.

Exclusion criteria - Patients who are mentioned shirodhara anarha and abhyanga anarha in classical text.

age group below 20 and above 60 yrs .

Patients with stroke ,heamorrhagic disorder , epilepsy and psychotic disorder .

Patients is on medication that cause sedation , chronic alcoholism , drug dependent .

Rashes, cut ,abrasion ,injury .

Withdrawal criteria - Sudden increase in sign and symptoms .

Patients want to discontinue treatment despite of giving consent .

Patients who will not following instruction and follow ups of treatment .

Patients who will not continuous for 7 days of treatment ..

Treatment administration

Grouping                   group A

Intervention                shirodhara

Drug                          Tila taila

Quantity                    1500 ml

Duration                    7 days

Time for Procedure   45 mins

Period of changing drug  Tila taila change every 3 days

Temperature                lukewarm

follow up                    After 7.14.21. days

Grouping                   Group B

Intervention                Abhyanga

Drug                           Tila taila

Quantity                      150 ml

Duration                     7 days

Time of procedure        35 mins

Period of changing drug  Fresh each day

Temperature                  lukewarm

Follow up                    After 7,14,21 days

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients fulfilling diagnostic criteria of Nidranasha and Insomnia.
  • Age group from 20 yrs To 60 yr .
  • Patients irrespective of gender, religion, economic status education occupation.

排除标准

  • Patients who are mentioned as Shirodhara and abhyanga anarha in classical text.
  • Age group below 20 yrs and above 60 Yrs.
  • Patients with stroke, hemorrhagic disorder, Epilepsy and other psychotic disorder.
  • Patients is on medication that can cause sedation, Chronic alcoholism , Drug dependency .
  • Rash, Cut, Abrasion , Injury .

结局指标

主要结局

To study Difference between efficacy of shirodhara and abhyanga to reduce symptoms of nidranasha .

时间窗: 7 days intervention with follow up on 7th , 14th ,21th day

次要结局

  • To study if there is no difference between efficacy of shirodhara and abhyanga to reduce symptoms of nidranasha .(7 days of intervention with follow up on 7th,14th,21th day .)

研究者

发起方
vdrutuja rangrao darekar
申办方类型
Other [self ]
责任方
Principal Investigator
主要研究者

Rutuja Rangrao Darekar

MES ayurveda mahavidyalay and research Center

研究点 (1)

Loading locations...

相似试验